Puma reports interim phase II data on neratinib in EGFR exon 18 mutated metastatic NSCLC Nov. 6, 2020
Oral mucositis treatment GC-4419 does not affect tumor control outcomes in phase II trial Nov. 6, 2020
Chinese clearance for phase III trial of APL-1202 for first-line nonmuscle invasive bladder cancer Nov. 5, 2020
E.U. approval of Lynparza with bevacizumab for first-line maintenance in HRD-positive ovarian cancer Nov. 5, 2020
RSS